William Blair Investment Management LLC Has $275.19 Million Stake in Agilent Technologies, Inc. $A

William Blair Investment Management LLC reduced its stake in Agilent Technologies, Inc. (NYSE:A) by 3.2% during the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 2,144,086 shares of the medical research company’s stock after selling 70,401 shares during the period. Agilent Technologies comprises approximately 0.7% of William Blair Investment Management LLC’s investment portfolio, making the stock its 25th largest position. William Blair Investment Management LLC owned 0.76% of Agilent Technologies worth $275,193,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors also recently made changes to their positions in A. Norges Bank bought a new position in Agilent Technologies in the 2nd quarter valued at approximately $395,088,000. AQR Capital Management LLC increased its holdings in shares of Agilent Technologies by 424.1% during the second quarter. AQR Capital Management LLC now owns 2,041,826 shares of the medical research company’s stock worth $240,956,000 after buying an additional 1,652,244 shares in the last quarter. Ameriprise Financial Inc. lifted its stake in shares of Agilent Technologies by 132.2% in the 2nd quarter. Ameriprise Financial Inc. now owns 2,354,111 shares of the medical research company’s stock valued at $277,807,000 after acquiring an additional 1,340,161 shares during the last quarter. Massachusetts Financial Services Co. MA lifted its stake in shares of Agilent Technologies by 10.7% in the 2nd quarter. Massachusetts Financial Services Co. MA now owns 13,227,387 shares of the medical research company’s stock valued at $1,560,964,000 after acquiring an additional 1,273,994 shares during the last quarter. Finally, Troy Asset Management Ltd boosted its holdings in shares of Agilent Technologies by 74.3% during the 2nd quarter. Troy Asset Management Ltd now owns 2,397,820 shares of the medical research company’s stock valued at $282,967,000 after acquiring an additional 1,021,865 shares in the last quarter.

Key Agilent Technologies News

Here are the key news stories impacting Agilent Technologies this week:

• Positive Sentiment: Management raised FY‑2026 revenue ambition to $7.3B–$7.5B and highlighted expansion of its Ignite operating system as a path to future margin improvement. Read More.
• Positive Sentiment: Most sell‑side firms remain constructive (buy/overweight) and retain multi‑quarter price targets well above the current level despite trimming targets this week — supporting medium‑term upside if growth/margins recover. Read More.
• Neutral Sentiment: Agilent issued Q2 FY2026 EPS guidance of $1.39–1.42 and FY EPS of $5.90–6.04, which sits roughly around Street expectations — guidance is not a major beat or miss. Read More.
• Neutral Sentiment: Q4/CY2025 results were reported in line with expectations earlier, so the current reaction is focused on Q1 specifics and forward execution rather than a broader trend break. Read More.
• Negative Sentiment: Q1 results narrowly missed: EPS $1.36 vs. $1.37 consensus and revenue ~$1.80B vs. ~$1.81–1.84B estimates — the miss (and a weak margin cadence) triggered a near‑term selloff in earnings reaction. Read More.
• Negative Sentiment: Management said a severe U.S. winter storm disrupted shipments and service in the quarter, pressuring near‑term revenue and gross margins — investors may see this as a risk to near‑term execution. Read More.
• Negative Sentiment: Operating profit and operating cash flow declined year‑over‑year (cash from operations down notably), which raises short‑term concerns about margin leverage and free‑cash‑flow conversion. Institutional trimming noted in recent filings adds to near‑term selling pressure. Read More.

Analyst Ratings Changes

A number of brokerages have issued reports on A. Morgan Stanley assumed coverage on Agilent Technologies in a report on Tuesday, December 2nd. They issued an “overweight” rating for the company. Citigroup upped their price objective on Agilent Technologies from $165.00 to $185.00 and gave the company a “buy” rating in a research note on Tuesday, November 25th. The Goldman Sachs Group began coverage on shares of Agilent Technologies in a research report on Tuesday, December 9th. They set a “buy” rating and a $170.00 target price on the stock. UBS Group reduced their target price on shares of Agilent Technologies from $180.00 to $165.00 and set a “buy” rating on the stock in a report on Thursday. Finally, Evercore raised shares of Agilent Technologies from an “in-line” rating to an “outperform” rating and raised their price target for the company from $155.00 to $160.00 in a research note on Monday, January 5th. Two equities research analysts have rated the stock with a Strong Buy rating, eleven have issued a Buy rating and three have issued a Hold rating to the stock. According to data from MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and a consensus price target of $161.29.

Agilent Technologies Stock Performance

Shares of A stock opened at $121.08 on Friday. The company has a debt-to-equity ratio of 0.45, a current ratio of 1.96 and a quick ratio of 1.52. Agilent Technologies, Inc. has a one year low of $96.43 and a one year high of $160.27. The business’s 50 day simple moving average is $134.67 and its 200 day simple moving average is $136.04. The stock has a market capitalization of $34.25 billion, a PE ratio of 26.73, a PEG ratio of 3.52 and a beta of 1.30.

Agilent Technologies (NYSE:A) last issued its quarterly earnings results on Wednesday, February 25th. The medical research company reported $1.36 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $1.37 by ($0.01). Agilent Technologies had a return on equity of 24.95% and a net margin of 18.26%.The firm had revenue of $1.80 billion during the quarter, compared to analyst estimates of $1.81 billion. During the same quarter last year, the firm posted $1.31 EPS. The firm’s revenue for the quarter was up 7.0% on a year-over-year basis. Agilent Technologies has set its FY 2026 guidance at 5.900-6.040 EPS and its Q2 2026 guidance at 1.390-1.420 EPS. As a group, research analysts forecast that Agilent Technologies, Inc. will post 5.58 earnings per share for the current year.

Agilent Technologies Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Wednesday, April 22nd. Shareholders of record on Tuesday, March 31st will be issued a dividend of $0.255 per share. This represents a $1.02 dividend on an annualized basis and a yield of 0.8%. The ex-dividend date is Tuesday, March 31st. Agilent Technologies’s dividend payout ratio (DPR) is presently 22.52%.

About Agilent Technologies

Agilent Technologies is a global provider of scientific instrumentation, consumables, software and services for laboratories across the life sciences, diagnostics and applied chemical markets. The company’s product portfolio includes analytical instruments such as liquid and gas chromatographs, mass spectrometers, spectroscopy systems, and laboratory automation solutions, together with reagents, supplies and informatics tools that support measurement, testing and data analysis workflows. Agilent also offers instrument maintenance, qualification and laboratory services designed to help customers improve productivity and comply with regulatory requirements.

Founded as a corporate spin-off from Hewlett‑Packard in 1999, Agilent has evolved through a combination of strategic restructuring and acquisitions to concentrate on life sciences, diagnostics and applied laboratories.